MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients (MelaViD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by European Institute of Oncology
Sponsor:
Information provided by (Responsible Party):
European Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01264874
First received: December 21, 2010
Last updated: October 8, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2025
  Estimated Primary Completion Date: February 2025 (Final data collection date for primary outcome measure)